Three strategies for managing loss of exclusivity successfully
pharmaphorum
FEBRUARY 18, 2021
Eli Lilly’s Humalog compound and formulation patents expired in 2013 and 2014, respectively. 6 The stakes were extremely high, with annual costs of insulin reaching $736 per patient in 2013, up threefold since 2002. RESULT: As of 2002, 40% of PRILOSEC patients had switched to NEXIUM, which notched up sales of $3.9
52 
Let's personalize your content